HAL (France)open access
Radionuclide Therapy of Prostate Cancer Using PSMA Ligands with a 4-Phenylbutyric Acid-Derived Albumin Binder: Recent Chemical and Clinical Advances
Radioligand Therapy, Prostate Cancer, Albumin Binders, 0, 2, 4-Phenylbutyric Acid, Targeted Radionuclide Therapy, Radiopharmaceuticals
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 424812
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.